Investor FAQs
Where is ImmunityBio headquartered?
3530 John Hopkins Court
San Diego, CA 92121
San Diego, CA 92121
Where is ImmunityBio incorporated?
ImmunityBio is incorporated in the State of Delaware.
Who are the members of ImmunityBio’s executive management team?
Information about ImmunityBio’s management team is available on the Leadership section of this website.
Who are the members of ImmunityBio's Board of Directors?
Information about ImmunityBio’s Board of Directors is available on the Directors section of this website.
When is ImmunityBio’s fiscal year end?
December 31st
On which exchange is ImmunityBio traded, what is the ticker symbol, and when did ImmunityBio go public?
ImmunityBio's common stock is traded under the ticker symbol [IBRX] on The NASDAQ Global Select Market.
How can I purchase shares of ImmunityBio?
Shares can be purchased through a stockbroker of your choice. ImmunityBio does not have a direct stock purchase program.
What is the CUSIP number for ImmunityBio’s common stock?
The CUSIP number is 45256X103.
Who is ImmunityBio’s independent registered accounting firm?
Ernst & Young LLP
Who is ImmunityBio’s transfer agent and how do I contact them?
Transfer Agent & Stockholder Services
Equiniti Trust Company, LLC
Equiniti Shareholder Services Call Center
Toll Free: 800.937.5449
Local & International: 718-921-8124
Hours: 8 a.m. – 8 p.m. ET Monday-Friday
Equiniti Trust Company, LLC
55 Challenger Road, Floor 2
Ridgefield Park, NJ 07660
Email
Website
How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
Transfer Agent & Stockholder Services
Equiniti Trust Company, LLC
Equiniti Shareholder Services Call Center
Toll Free: 800.937.5449
Local & International: 718-921-8124
Hours: 8 a.m. – 8 p.m. ET Monday-Friday
Equiniti Trust Company, LLC
55 Challenger Road, Floor 2
Ridgefield Park, NJ 07660
Email
Website
Does ImmunityBio pay dividends?
We have never paid cash dividends on our common stock and do not anticipate paying cash dividends on our common stock for the foreseeable future. The payment of dividends on our common stock will depend on earnings, financial condition, restrictive covenants under our financing arrangements, including our revenue interest liability, as applicable, and other business and economic factors affecting us at such time as the Board of Directors may consider relevant.
Where can I get the latest corporate news releases and financial reports?
Copies of ImmunityBio’s news releases are available in the Investors section of this website.
How can I get copies of ImmunityBio’s filings with the Securities & Exchange Commission (SEC)?
Copies of ImmunityBio’s filings with the SEC can be accessed through the Financial Information section of this website or directly from the SEC at www.sec.gov.
How can I sign up to receive ImmunityBio’s press releases and other company information?
You can sign up to receive ImmunityBio press releases and other company information via Email Alerts.
Who do I contact Investor Relations with questions or requests?
Please complete the Information Request form.